• 1
    Adelstein DJ, Tan EH, Lavertu P. Treatment of head and neck cancer: the role of chemotherapy. Crit Rev Oncol Hematol 1996; 24: 97116.
  • 2
    Fu KK. Combined-modality therapy for head and neck cancer. Oncology 1997; 11: 178196.
  • 3
    Smid L, Lesnicar H, Zakotnik B, Soba E, Budihna M, Furlan L, et al. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer-preliminary report. Int J Radiat Oncol Biol Phys 1995; 32: 76975.
  • 4
    Wendt TG, Grabenbauer GG, Rödel CM, Thiel HJ, Aydin H, Rohloff R, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998; 16: 131824.
  • 5
    Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798804.
  • 6
    Calais G, Alfonsi M, Bardet E, Sire C, Bourgeois H, Bergerot C, et al. Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma (ARCORO). Preliminary results of the 94.01 study from the French Group of Radiation Oncology for Head and Neck Cancer (GORTEC) [abstract 1484]. Proc Am Soc Clin Oncol 1998; 17: 385a.
  • 7
    Munro AJ. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 8391.
  • 8
    El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14: 83847.
  • 9
    Bourhis J, Pignon JP, Designé L, Luboinski M, Guerin S, Domenge C. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): (1) Loco-regional treatment vs same treatment + chemotherapy (CT) [abstract 1486]. Proc Am Soc Clin Oncol 1998; 17: 386a.
  • 10
    Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994; 86: 1317.
  • 11
    Schwartz LH, Ozsahin M, Zhang GN, Touboul E, DeVataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74: 19338.
  • 12
    Adelstein DJ, Saxton JP, Lavertu P, Tuason L, Wood BG, Wanamaker JR, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997; 19: 56775.
  • 13
    Beahrs OH, Henson DE, Hutter RVP, Myers MH. Manual for staging of cancer. 3rd edition. American Joint Committee on Cancer. Philadelphia: J.B. Lippincott Co., 1988.
  • 14
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 45781.
  • 15
    The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 168590.
  • 16
    Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996; 88: 8909.
  • 17
    Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology 1997; 11: 6519.
  • 18
    List MA, Butler P, Vokes EE, Kies M, Ganzenko N, Lundy D, et al. Head and neck cancer (HNC) patients: how do patients prioritize potential treatment outcomes? [abstract 1472]. Proc Am Soc Clin Oncol 1998;17: 382a.